Transmembrane Helical Domain of the Cannabinoid CB1 Receptor

被引:27
|
作者
Shim, Joong-Youn [1 ]
机构
[1] N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC USA
基金
美国国家科学基金会;
关键词
PROTEIN-COUPLED-RECEPTOR; MOLECULAR-DYNAMICS SIMULATION; INTERNAL WATER-MOLECULES; MEMBRANE ENVIRONMENT; SIGNAL-TRANSDUCTION; SECONDARY STRUCTURE; SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; RHODOPSIN FAMILY; ACTIVATION;
D O I
10.1016/j.bpj.2008.12.3934
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Brain cannabinoid (CB1) receptors are G-protein coupled receptors and belong to the rhodopsin-like subfamily. A homology model of the inactive state of the CB, receptor was constructed using the x-ray structure Of beta(2)-adrenergic receptor (beta(2)AR) as the template. We used 105 ns duration molecular-dynamics simulations of the CB1 receptor embedded in a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayer to gain some insight into the structure and function of the CB1 receptor. As judged from the root mean-square deviations combined with the detailed structural analyses, the helical bundle of the CB1 receptor appears to be fully converged in 50 ns of the simulation. The results reveal that the helical bundle structure of the CB1 receptor maintains a topology quite similar to the x-ray structures of G-protein coupled receptors overall. It is also revealed that the CB1 receptor is stabilized by the formation of extensive, water-mediated H-bond networks, aromatic stacking interactions, and receptor-lipid interactions within the helical core region. It is likely that these interactions, which are often specific to functional motifs, including the S(N)LAxAD, D(E)RY, CWxP, and NPxxY motifs, are the molecular constraints imposed on the inactive state of the CB1 receptor. It appears that disruption of these specific interactions is necessary to release the molecular constraints to achieve a conformational change of the receptor suitable for G-protein activation.
引用
收藏
页码:3251 / 3262
页数:12
相关论文
共 50 条
  • [41] Structure of an allosteric modulator bound to the CB1 cannabinoid receptor
    Zhenhua Shao
    Wei Yan
    Karen Chapman
    Karthik Ramesh
    Aaron J. Ferrell
    Jie Yin
    Xuehui Wang
    Qingping Xu
    Daniel M. Rosenbaum
    [J]. Nature Chemical Biology, 2019, 15 : 1199 - 1205
  • [42] Steric trigger as a mechanism for CB1 cannabinoid receptor activation
    Shim, JY
    Howlett, AC
    [J]. JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (04): : 1466 - 1476
  • [43] CB1 cannabinoid receptor-mediated cell migration
    Song, ZH
    Zhong, M
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 294 (01): : 204 - 209
  • [44] Cannabinoid CB1 receptor expression in rat spinal cord
    Farquhar-Smith, WP
    Egertová, M
    Bradbury, EJ
    McMahon, SB
    Rice, ASC
    Elphick, MR
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2000, 15 (06) : 510 - 521
  • [45] CB1 cannabinoid receptor signalling in Parkinson's disease
    Brotchie, JM
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (01) : 54 - 61
  • [46] Loss of Cannabinoid Receptor CB1 Induces Preterm Birth
    Wang, Haibin
    Xie, Huirong
    Dey, Sudhansu K.
    [J]. PLOS ONE, 2008, 3 (10):
  • [47] Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectives
    Lange, Jos H. M.
    Kruse, Chris G.
    [J]. CHEMICAL RECORD, 2008, 8 (03): : 156 - 168
  • [48] Recent CB1 Cannabinoid Receptor Antagonists and Inverse Agonists
    Seltzman, Herbert H.
    [J]. DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 601 - 615
  • [49] The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons
    Lau, Thorsten
    Schloss, Patrick
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 578 (2-3) : 137 - 141
  • [50] Molecular basis for ligand modulation of the cannabinoid CB1 receptor
    Ramesh, Karthik
    Rosenbaum, Daniel M.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (14) : 3487 - 3495